Autopsy report · NCT03703908

A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome

“Program not advancing”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 1 year 9 months before it stopped.
• 5 participants enrolled.
• Results were posted on the registry 3 years 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Amgen

Sponsor type

Industry

Conditions

Focal Segmental Glomerulosclerosis

Interventions

CCX140-B

Participants

5

Sites

5

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.